Research Article

Course of Hyperkalemia in Patients on Hemodialysis

Figure 2

Proportions of placebo patients with predialysis sK+ ranges of (a) 4.0–5.0 mmol/L and (b) 4.0–5.5 mmol/L at each study visit, by predialysis sK+ concentration at randomization. Predialysis sK+ measurement at randomization (visit 4, day 1) was used for subgroup stratification. Patients receiving rescue therapy were included in the analysis. No imputation of missing data was conducted. L represents the LIDI visits. LIDI, long interdialytic interval; sK+, serum potassium.
(a)
(b)